Announced
Completed
Synopsis
Eliquent Life Sciences, a global regulatory consulting firm for the life sciences industry, completed the acquisition of RApport Global Strategic Services, a UK based international regulatory consultancy. Financial terms were not disclosed. “Today’s announcement further positions ELIQUENT as a leader in global regulatory consulting and underscores our commitment to delivering value to our clients. I look forward to partnering with the talented RApport team as we offer our clients an expanded portfolio of solutions designed to streamline market entry and compliance strategies worldwide,” Tim Dietlin, ELIQUENT Life Sciences CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.